Filing search / Ownership / COSCIENS Biopharma Inc. / Page 13

6-K

rvorrem

6 Jun 19

Aeterna Zentaris Provides Corporate Update

2:30pm

8-A12B/A

5905vtf7k3jx7xl25v54

9 May 19

Registration of securities on exchange (amended)

4:23pm

6-K

850bw

9 May 19

Report as to Voting Results

4:05pm

6-K

x1ak786

9 May 19

Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting

12:00am

6-K

z3dxafl303o

7 May 19

Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results

5:22pm

6-K

aale2xxqwb62

7 May 19

Condensed Interim Consolidated Financial Statements

4:38pm

6-K

45glrs gyebn42tz

1 Apr 19

Current report (foreign)

12:00am

6-K

abqsolj9q9l4ve

27 Mar 19

Annual and Special Meeting

2:02pm

6-K

rp00ljoe

26 Mar 19

Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results

5:26pm

UPLOAD

hcl mr243l

25 Mar 19

Letter from SEC

12:00am

6-K

t6htd25p23e430a4

22 Mar 19

Material Change Report

4:40pm

6-K

bosbwh9gzkdkbgbvdfk0

19 Mar 19

Current report (foreign)

8:00am

6-K

om90q3pkkn jr53dsbf

12 Mar 19

Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor

4:49pm

CORRESP

6dhd4

12 Mar 19

Correspondence with SEC

12:00am

UPLOAD

11egqtqhueaumb1ar

25 Feb 19

Letter from SEC

12:00am

6-K

ec57jlfe

22 Feb 19

Current report (foreign)

1:16pm

CORRESP

1kvkfz ik4zs5292ag

18 Jan 19

Correspondence with SEC

12:00am

6-K

ep0fo

16 Jan 19

Aeterna Zentaris Receives European Marketing Clearance for Macimorelin

9:08am

6-K

2kql1 qpa

21 Dec 18

Current report (foreign)

5:10pm